See you soon!

Bioprose recently partnered with an international precision medicine and health informatics company that is developing a novel body fat and muscle composition analysis platform, in order to optimize their commercial positioning and information dissemination strategy as they begin to reveal new data stemming from their involvement in multiple high-profile clinical trials.

Bioprose is working closely with the client cross-functional team- integrating perspectives from regulatory, commercial, marketing, and science/medical to draft commercial communication materials that establish an effective value proposition for the technology.

These materials include press releases, social channel posts, blog articles, and website content; as well as helping to develop concrete value messages centered around the technology’s utility in clinical trials.

As of July 2024, Bioprose has implemented new methodologies with the client team on effective science writing strategies to incorporate into a large number of press releases that communicate the company’s value and involvement in trials across the metabolic/GLP-1 space, neuromuscular disease, and more.

The client is extremely satisfied with the narrative(s) currently in development surrounding their technology and company mission- with plans to retain Bioprose and continue releasing material to the press regarding multiple clinical research involvements they are actively engaged in.

The client team is confident in Bioprose as a strategic thought partner that will continuously develop effective science communication strategies for various audiences, and helping to shape the brand’s identity among pharma & clinical care stakeholders.

Bioprose recently partnered with a small, local public health department in the midwestern US to help review and streamline their annual health report for 2023.

Annual reports are an incredibly useful tool for public health agencies to communicate the overall health landscape of the region they serve, by providing statistics on topics including but not limited to birth and mortality rates, infectious disease prevalence, drug abuse and addiction, and family planning.

Bioprose helped this agency draft their 2023 Annual Report through edits and revisions made in conjunction with the internal team; most of which focused on adjusting the writing style to emphasize the key takeaways from the biostatistics being shared with the community, in order to ensure the citizens could easily digest important information regarding their community’s health status.